WCM
ANIP icon

Wedge Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Wedge Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
19,367
-923
-5% -$74K 0.03% 364
2026
Q1 		$1.56M Buy
20,290
+3,278
+19% +$256K 0.03% 389
2025
Q4 		$1.34M Sell
17,012
-216
-1% -$18.7K 0.02% 394
2025
Q3 		$1.58M Sell
17,228
-6,925
-29% -$565K 0.03% 375
2025
Q2 		$1.58M Sell
24,153
-15
-0.1% -$977 0.03% 365
2025
Q1 		$1.62M Sell
24,168
-8,048
-25% -$481K 0.03% 350
2024
Q4 		$1.78M Sell
32,216
-26,466
-45% -$1.52M 0.03% 344
2024
Q3 		$3.5M Sell
58,682
-3,279
-5% -$200K 0.06% 253
2024
Q2 		$3.95M Sell
61,961
-18,900
-23% -$1.23M 0.07% 231
2024
Q1 		$5.59M Buy
80,861
+15,330
+23% +$925K 0.09% 213
2023
Q4 		$3.61M Buy
65,531
+1,958
+3% +$108K 0.06% 267
2023
Q3 		$3.69M Sell
63,573
-43,905
-41% -$2.53M 0.07% 260
2023
Q2 		$5.79M Sell
107,478
-11,467
-10% -$508K 0.09% 260
2023
Q1 		$4.72M Sell
118,945
-5,325
-4% -$225K 0.08% 271
2022
Q4 		$5M Sell
124,270
-5,485
-4% -$206K 0.08% 269
2022
Q3 		$4.17M Buy
+129,755
New +$4.44M 0.07% 274
2020
Q2 		– Sell
-5,710
Closed -$233K – 515
2020
Q1 		$233K Buy
5,710
+335
+6% +$17.8K ﹤0.01% 438
2019
Q4 		$331K Buy
5,375
+1,016
+23% +$67.3K ﹤0.01% 456
2019
Q3 		$318K Sell
4,359
-3,027
-41% -$226K ﹤0.01% 474
2019
Q2 		$607K Buy
7,386
+586
+9% +$41.7K 0.01% 430
2019
Q1 		$480K Buy
+6,800
New +$400K 0.01% 460

Other funds holding ANIP

MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

Wedge Capital Management's ANIP Position: Q2 2026 in Review

Wedge Capital Management reduced its ANI Pharmaceuticals (ANIP) stake by 4.5% in Q2 2026, selling an estimated $74K and leaving 19,367 shares worth $1.6M. The position accounts for 0.03% of the portfolio, ranked #364.

Wedge Capital Management first reported a position in ANIP in Q1 2019 and has held it in 21 quarters since. The position peaked at $5.79M in Q2 2023. 39 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Wedge Capital Management held 19,367 shares of ANI Pharmaceuticals worth $1.6M as of Q2 2026.
  • Wedge Capital Management sold 923 ANI Pharmaceuticals shares in Q2 2026, an estimated $74K.
  • ANI Pharmaceuticals made up 0.03% of Wedge Capital Management's portfolio in Q2 2026, its #364 holding.
  • Wedge Capital Management first reported a position in ANI Pharmaceuticals in Q1 2019 and has held it in 21 quarters since.
  • Wedge Capital Management's ANI Pharmaceuticals position peaked at $5.79M in Q2 2023.
  • 39 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.